Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)
Vietnam
· Delayed Price · Currency is VND 142,000
0.00 (0.00%)
At close: Mar 9, 2026
HNX:PMC Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,325,225 | 1,541,741 | 970,588 | 803,535 | 793,269 | 611,284 | Upgrade
|
| Market Cap Growth | 26.79% | 58.85% | 20.79% | 1.29% | 29.77% | 13.91% | Upgrade
|
| Enterprise Value | 1,284,342 | 1,509,383 | 739,173 | 475,122 | 508,725 | 375,105 | Upgrade
|
| Last Close Price | 142000.00 | 165200.00 | 94261.89 | 69205.85 | 56879.42 | 42226.33 | Upgrade
|
| PE Ratio | 16.10 | 18.73 | 16.59 | 13.17 | 13.03 | 12.93 | Upgrade
|
| PS Ratio | 2.42 | 2.82 | 1.95 | 1.66 | 1.68 | 1.48 | Upgrade
|
| PB Ratio | 5.50 | 6.40 | 3.35 | 2.34 | 1.85 | 1.57 | Upgrade
|
| P/TBV Ratio | 5.55 | 6.46 | 3.38 | 2.36 | 1.87 | 1.58 | Upgrade
|
| P/FCF Ratio | - | - | 24.74 | 9.27 | 25.04 | 10.38 | Upgrade
|
| P/OCF Ratio | 71.76 | 83.48 | 17.98 | 8.49 | 21.44 | 9.73 | Upgrade
|
| EV/Sales Ratio | 2.35 | 2.76 | 1.48 | 0.98 | 1.08 | 0.91 | Upgrade
|
| EV/EBITDA Ratio | 11.70 | 13.75 | 7.26 | 4.93 | 4.92 | 4.33 | Upgrade
|
| EV/EBIT Ratio | 13.12 | 15.42 | 8.17 | 5.63 | 5.61 | 5.17 | Upgrade
|
| EV/FCF Ratio | -21.79 | - | 18.84 | 5.48 | 16.06 | 6.37 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | - | - | - | - | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.17 | -0.17 | -0.69 | -0.76 | -0.69 | -0.70 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.37 | -0.37 | -1.98 | -2.72 | -2.84 | -3.14 | Upgrade
|
| Net Debt / FCF Ratio | 0.69 | 0.69 | -5.13 | -3.03 | -9.27 | -4.61 | Upgrade
|
| Asset Turnover | 1.52 | 1.52 | 1.24 | 1.05 | 1.00 | 0.94 | Upgrade
|
| Inventory Turnover | 3.62 | 3.62 | 4.50 | 3.67 | 3.25 | 3.32 | Upgrade
|
| Quick Ratio | 0.72 | 0.72 | 2.85 | 3.67 | 5.01 | 5.00 | Upgrade
|
| Current Ratio | 2.10 | 2.10 | 3.89 | 4.56 | 6.65 | 6.21 | Upgrade
|
| Return on Equity (ROE) | 31.03% | 31.03% | 25.33% | 21.68% | 20.43% | 17.20% | Upgrade
|
| Return on Assets (ROA) | 16.97% | 16.97% | 14.10% | 11.46% | 12.00% | 10.30% | Upgrade
|
| Return on Invested Capital (ROIC) | 38.68% | 54.20% | 85.30% | 62.68% | 57.62% | 45.36% | Upgrade
|
| Return on Capital Employed (ROCE) | 40.60% | 40.60% | 31.20% | 24.60% | 21.20% | 18.70% | Upgrade
|
| Earnings Yield | 6.21% | 5.34% | 8.26% | 10.40% | 10.52% | 10.59% | Upgrade
|
| FCF Yield | -4.45% | -3.82% | 4.04% | 10.79% | 3.99% | 9.63% | Upgrade
|
| Dividend Yield | 1.69% | - | 2.55% | 27.60% | 5.27% | 5.68% | Upgrade
|
| Payout Ratio | 132.30% | 120.44% | 137.95% | 164.60% | 27.30% | 33.44% | Upgrade
|
| Total Shareholder Return | 1.69% | - | 2.55% | 27.60% | 5.27% | 5.68% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.